NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
02/24/2026
Back to search
Official data from USPTO
GALAPAGOS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GALAPAGOS
ST13
US500000088110392Class
5, 42, 44
Filing
88110392
Registration
5888518
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
03/17/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
09/10/2018
Registration date
10/22/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/24/2026
Last transaction
03/17/2026
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
Mechelen, BE
Examiner
GASKINS, TONJA M
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Galapagos N.V.
Representatives
Alexandra MacKay STITES & HARBISON, PLLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical substances and preparations for human usefor the treatment of bone cartilage and joint diseaseautoinflammation diseasesautoimmune diseasesproliferative diseasesendocrine diseasesmetabolic diseasesskin diseaseslung diseasesfibrotic diseasescardiovascular diseasespainhepatitis B viruskidney diseasesosteoporosisosteoarthritisrheumatoid arthritisatopic dermatitisidiopathic pulmonary fibrosisinflammatory bowel diseaseCrohn's diseaseulcerative colitisankylosing spondylitispsoriatic arthritisSjogren's syndromelupusuveitissclerodermanon-alcoholic steatohepatitispolycystic kidney diseasetype 2 diabetes ; biopharmaceutical substances and preparations for human usefor the treatment of bone cartilage and joint diseaseautoinflammation diseasesautoimmune diseasesproliferative diseasesendocrine diseasesmetabolic diseasesskin diseaseslung diseasesfibrotic diseasescardiovascular diseasespainhepatitis B viruskidney diseasesosteoporosisosteoarthritisrheumatoid arthritisatopic dermatitisidiopathic pulmonary fibrosisinflammatory bowel diseaseCrohn's diseaseulcerative colitisankylosing spondylitispsoriatic arthritisSjogren's syndromelupusuveitissclerodermanon-alcoholic steatohepatitispolycystic kidney diseasetype 2 diabetes
Class 42
medical and scientific research services; industrial research services in the field of assay developmenttarget discovery and validationdrug developmentmedicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific researchthe examination and testing of genes; developmentlaboratory analysistesting of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; developmentlaboratory analysistesting of medicaments; the development of clinical assayscellular teststesting kitsdiagnostic kitscompanion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medicalpharmaceutical and biopharmaceutical fields and gathering of data to populate same via collection of medicalpharmaceuticalbiopharmaceutical research and clinical trial data; and gene bank services for research purposes
Class 44
medical services; medical and pharmaceutical advisory and consultancy services; gene bank services
Publications
History of USPTO decisions and trademark events.
27 publications found
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
02/24/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/23/2026
ES8R
TEAS SECTION 8 RECEIVED
10/06/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/22/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2019
PUBO
PUBLISHED FOR OPPOSITION
08/06/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
07/02/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/28/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
06/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/27/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/27/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/27/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/08/2019
GNRT
NON-FINAL ACTION E-MAILED
01/08/2019
CNRT
NON-FINAL ACTION WRITTEN
01/08/2019
DOCK
ASSIGNED TO EXAMINER
12/19/2018
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/22/2018
ALIE
ASSIGNED TO LIE
10/18/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/09/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/17/2018
NWAP
NEW APPLICATION ENTERED
09/13/2018
Continuous trademark protection
Get notified about every new filing that threatens GALAPAGOS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.